Src kinase activation by nitric oxide promotes resistance to anoikis in tumour cell lines

References

• Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275–292.
   PubMed Web of Science ®Google Scholar
• Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol. 2001;13(5):555–562.
   PubMed Web of Science ®Google Scholar
• Fidler IJ. The pathogenesis of cancer metastasis: the “seed and soil” hypothesis revisited. Nat Rev Cancer. 2003;3(6):453–458.
   PubMed Web of Science ®Google Scholar
• Gilmore AP, Anoikis. Cell Death Differ. 2005;2:1473–1477.
   Google Scholar
• Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285(5430):1028–1032.
   PubMed Web of Science ®Google Scholar
• Di Florio A, Capurso G, Milione M, et al. Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells. Endocr Relat Cancer. 2007;14(1):111–124.
   PubMed Web of Science ®Google Scholar
• Beierle EA, Ma X, Trujillo A, et al. Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines. Mol Carcinog. 2010;49(3):224–234.
   PubMed Web of Science ®Google Scholar
• Roskoski R Jr. Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun. 2004;324(4):1155–1164.
   PubMed Web of Science ®Google Scholar
• Yeatman TJ. A renaissance for SRC. Nat Rev Cancer. 2004;4(6):470–480.
   PubMed Web of Science ®Google Scholar
• Windham TC, Parikh NU, Siwak DR, et al. Src activation regulates anoikis in human colon tumor cell lines. Oncogene. 2002;21(51):7797–7807.
   PubMed Web of Science ®Google Scholar
• Wei L, Yang Y, Zhang X, et al. Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene. 2004;23(56):9052–9061.
   PubMed Web of Science ®Google Scholar
• Díaz-Montero CM, Wygant JN, McIntyre BW. PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation. Eur J Cancer. 2006;42(10):1491–1500.
   PubMed Web of Science ®Google Scholar
• Rahman MA, Senga T, Ito S, et al. S-nitrosylation at cysteine 498 of C-src tyrosine kinase regulates nitric oxide-mediated cell invasion. J Biol Chem. 2010;285(6):3806–3814.
   PubMed Web of Science ®Google Scholar
• Curcio MF, Batista WL, Linares E, et al. Regulatory effects of nitric oxide on Src kinase, FAK, p130Cas, and receptor protein tyrosine phosphatase alpha (PTP-alpha): a role for the cellular redox environment. Antioxid Redox Signal. 2010;13(2):109–125.
   PubMed Web of Science ®Google Scholar
• Andre FR, dos Santos PF, Rando DG. Theoretical studies of the role of C-terminal cysteines in the process of S-nitrosylation of human Src kinases. J Mol Model. 2016;22(1):23.
   PubMed Web of Science ®Google Scholar
• McHugh J, Cheek DJ. Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations. Am J Crit Care. 1998;7(2):131–40; quiz 141.
   PubMedGoogle Scholar
• Christopherson KS, Bredt DS. Nitric oxide in excitable tissues: physiological roles and disease. J Clin Invest. 1997;100(10):2424–2429.
   PubMed Web of Science ®Google Scholar
• Oliveira CJ, Curcio MF, Moraes MS, et al. The low molecular weight S-nitrosothiol, S-nitroso-N-acetylpenicillamine, promotes cell cycle progression in rabbit aortic endothelial cells. Nitric Oxide. 2008;18(4):241–255.
   PubMed Web of Science ®Google Scholar
• Batista WL, Ogata FT, Curcio MF, et al. S-nitrosoglutathione and endothelial nitric oxide synthase-derived nitric oxide regulate compartmentalized ras S-nitrosylation and stimulate cell proliferation. Antioxid Redox Signal. 2013;18(3):221–238.
   PubMed Web of Science ®Google Scholar
• Napoli C, Paolisso G, Casamassimi A, et al. Effects of nitric oxide on cell proliferation: novel insights. J Am Coll Cardiol. 2013;62(2):89–95.
   PubMed Web of Science ®Google Scholar
• Chae IH, Park KW, Kim HS, et al. Nitric oxide-induced apoptosis is mediated by Bax/Bcl-2 gene expression, transition of cytochrome c, and activation of caspase-3 in rat vascular smooth muscle cells. Clin Chim Acta. 2004;341(1–2):83–91.
   PubMed Web of Science ®Google Scholar
• Da Costa PE, Batista WL, Curcio MF, et al. Protein tyrosine phosphatase alpha regulates cell detachment and cell death profiles induced by nitric oxide donors in the A431 human carcinoma cell line. Redox Rep. 2011;16(1):27–37.
   PubMed Web of Science ®Google Scholar
• Monteiro HP, Costa PE, Reis AK, et al. Nitric oxide: protein tyrosine phosphorylation and protein S-nitrosylation in cancer. Biomed J. 2015;38(5):380–388.
   PubMed Web of Science ®Google Scholar
• Vannini F, Kashfi K, Nath N. The dual role of iNOS in cancer. Redox Biol. 2015;6:334–343.
   PubMed Web of Science ®Google Scholar
• Wynia-Smith SL, Smith BC. Nitrosothiol formation and S-nitrosation signaling through nitric oxide synthases. Nitric Oxide. 2017;63:52–60.
   PubMed Web of Science ®Google Scholar
• Wang J, Lu S, Moënne-Loccoz P, et al. Interaction of nitric oxide with human heme oxygenase-1. J Biol Chem. 2003;278(4):2341–2347.
   PubMed Web of Science ®Google Scholar
• Adams C, McCarthy HO, Coulter JA, et al. Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells. J Gene Med. 2009;11(2):160–168.
   PubMed Web of Science ®Google Scholar
• Glynn SA, Boersma BJ, Dorsey TH, et al. Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. J Clin Invest. 2010;120(11):3843–3854.
   PubMed Web of Science ®Google Scholar
• De Oliveira GA, Cheng RYS, Ridnour LA, et al. Inducible nitric oxide synthase in the carcinogenesis of gastrointestinal cancers. Antioxid Redox Signal. 2017;26(18):1059–1077.
   PubMed Web of Science ®Google Scholar
• Grimm EA, Ellerhorst J, Tang CH, et al. Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis. Nitric Oxide. 2008;19(2):133–137.
   PubMed Web of Science ®Google Scholar
• Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer. 2006;6(7):521–534.
   PubMed Web of Science ®Google Scholar
• Hampl V, Walters CL, Archer SL. Determinations of nitric oxide by the chemiluminescence reactions with ozone. In: Feelisch MS, Stamler JS, eds. Methods in nitric oxide research. West Sussex, England: John Wiley & Sons; 1996. p. 309–318.
   Google Scholar
• Keefer LK. Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities. Curr Top Med Chem. 2005;5(7):625–636.
   PubMed Web of Science ®Google Scholar
• Riss T. Is your MTT assay really the best choice? [cited 2017 May 5] Available from: http://www.promega.com.br/resources/pubhub/is-your-mtt-assay-really-the-best-choice.
   Google Scholar
• Forrester MT, Foster MW, Benhar M, et al. Detection of protein S-nitrosylation with the biotin-switch technique. Free Radic Biol Med. 2009;46(2):119–126.
   PubMed Web of Science ®Google Scholar
• Liu Y, Bishop A, Witucki L, et al. Structural basis for selective inhibition of Src family kinases by PP1. Chem Biol. 1999;6(9):671–678.
   PubMed Web of Science ®Google Scholar
• Xue Y, Liu Z, Gao X, et al. GPS-SNO: computational prediction of protein S-nitrosylation sites with a modified GPS algorithm. PLoS ONE. 2010;5(6):e11290.
   PubMed Web of Science ®Google Scholar
• Cheng H, Wang L, Mollica M, et al. Nitric oxide in cancer metastasis. Cancer Lett. 2014;353(1):1–7.
   PubMed Web of Science ®Google Scholar
• Lahiri M, Martin JH. Nitric oxide decreases motility and increases adhesion in human breast cancer cells. Oncol Rep. 2009;21(2):275–281.
   PubMed Web of Science ®Google Scholar
• Ridnour LA, Thomas DD, Switzer C, et al. Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide. 2008;19(2):73–76.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Abrams JM, et al. Molecular definitions of cell death subroutines: recommendations of the nomenclature committee on cell death 2012. Cell Death Differ. 2012;19(1):107–120.
   PubMed Web of Science ®Google Scholar
• Haenssen KK, Caldwell SA, Shahriari KS, et al. ErbB2 requires integrin α5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells. J Cell Sci. 2010;123(8):1373–1382.
   PubMed Web of Science ®Google Scholar
• Maejima Y, Adachi S, Morikawa K, et al. Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation. J Mol Cell Cardiol. 2005;38(1):163–174.
   PubMed Web of Science ®Google Scholar
• Shen X, Burguillos MA, Osman AM, et al. Glioma-induced inhibition of caspase-3 in microglia promotes a tumor-supportive phenotype. Nat Immunol. 2016;17(11):1282–1290.
   PubMed Web of Science ®Google Scholar
• Oo ML, Senga T, Thant AA, et al. Cysteine residues in the C-terminal lobe of Src: their role in the suppression of the Src kinase. Oncogene. 2003;22(9):1411–1417.
   PubMed Web of Science ®Google Scholar
• Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol. 2006;18(5):516–523.
   PubMed Web of Science ®Google Scholar
• Beauséjour M, Noël D, Thibodeau S, et al. Integrin/Fak/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: selective engagement and roles of PI3-K isoform complexes. Apoptosis. 2012;17(6):566–578.
   PubMed Web of Science ®Google Scholar
• Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69(1):11–25.
   PubMed Web of Science ®Google Scholar
• Chanvorachote P, Pongrakhananon V, Chunhacha P. Prolonged nitric oxide exposure enhances anoikis resistance and migration through epithelial-mesenchymal transition and caveolin-1 upregulation. BioMed Res Int. 2014;2014:941359.
   PubMed Web of Science ®Google Scholar
• Glenney JR Jr. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J Biol Chem. 1989;264(34):20163–20166.
   PubMed Web of Science ®Google Scholar
• Gottlieb-Abraham E, Shvartsman DE, Donaldson JC, et al. Src-mediated caveolin-1 phosphorylation affects the targeting of active Src to specific membrane sites. Mol Biol Cell. 2013;24(24):3881–3895.
   PubMed Web of Science ®Google Scholar
• Powan P, Chanvorachote P. Nitric oxide mediates cell aggregation and mesenchymal to epithelial transition in anoikis-resistant lung cancer cells. Mol Cell Biochem. 2014;393(1–2):237–245.
   PubMed Web of Science ®Google Scholar
• Monteiro HP, Silva EF, Stern A. Nitric oxide: a potential inducer of adhesion-related apoptosis - anoikis. Nitric Oxide. 2004;10(1):1–10.
   PubMed Web of Science ®Google Scholar
• Avizienyte E, Wyke AW, Jones RJ, et al. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol. 2002;4(8):632–638.
   PubMed Web of Science ®Google Scholar
• Fujita Y, Krause G, Scheffner M, et al. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol. 2002;4(3):222–231.
   PubMed Web of Science ®Google Scholar
• Zhong X, Rescorla FJ. Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cell Signal. 2012;24(2):393–401.
   PubMed Web of Science ®Google Scholar
• Giannoni E, Fiaschi T, Ramponi G, et al. Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene. 2009;28(20):2074–2086.
   PubMed Web of Science ®Google Scholar
• Giannoni E, Buricchi F, Raugei G, et al. Intracellular reactive oxygen species activate src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol. 2005;25(15):6391–6403.
   PubMed Web of Science ®Google Scholar
• Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579–591.
   PubMed Web of Science ®Google Scholar
• Ruma IM, Putranto EW, Kondo E, et al. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding. Clin Exp Metastasis. 2016;33(6):609–627.
   PubMed Web of Science ®Google Scholar